SOPHiA GENETICS S.A.

NASDAQ:SOPH

Medical - Healthcare Information Services

Healthcare
$7.47 +0.38%

+$0.02 today

Market cap
$635.90M
Beta
0.98
P/E (TTM)
-4.6
EPS (TTM)
-$1.14
52W Low $2.59High $5.70

Volume 0.61M

Average 0.10M

SOPH Operating Margin

Operating income as a percentage of revenue, showing the profitability of core operations.

SOPHiA GENETICS S.A.NASDAQ: SOPH

Operating Margin · Q1 FY2026 · quarter ended Mar 2026

Operating margin widens to -79.7%

Operating margin was -79.7% in Q1 FY2026, up 10.5 pp from a year earlier. On a trailing-twelve-month basis it was -88.4%, up 6.7 pp year over year. Over 3 fiscal years it widened by 92.9 pp.

Context

  • Operating margin widened in 3 of the last 3 fiscal years.
  • FY2025 was the highest level in the 4 fiscal years shown.

What to watch

Whether operating margin reaches the consensus estimate from 4 analysts of -65.2% for the fiscal year ending Dec 2026, up from -91.8% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
-79.7%+3.5 pp QoQ
Last fiscal yearDec 2025
-91.8%+10.4 pp YoY
LTMMar 2026
-88.4%+6.7 pp YoY
Operating Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+10.5 pp+26.1 pp+15.5 pp
1 year+10.4 pp+26.6 pp+16.2 pp
3 years+92.9 pp+71.5 pp-21.4 pp
5 years+106.6 pp—
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Operating Margin history

Percent of revenue · from the income statement

Latest · FY2025
-91.8%
Year-over-year change
+10.4pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Operating Margin vs competitors

How SOPH compares with its peers on the latest reported figures

  • SOPH's LTM Mar 2026 operating margin of -88.4% is the 9th highest of the 10 companies compared; the peer median is 7.5%.
  • Its year-over-year change of +6.7 pp is the 4th highest of 10, against a peer median of +2.4 pp.
  • Over three fiscal years its change of +92.9 pp compares with a peer median of +11.3 pp.
SOPH Competitors Peer median
Operating Margin for SOPH and competitors
Company Period LTM level YoY 3-year change
DHDefinitive Healthcare Corp.LTM Mar 202666.9% +421.6 pp+11.3 pp
NRCNational Research CorporationLTM Mar 202614.1% -10.7 pp-14.3 pp
OPRXOptimizeRx CorporationLTM Mar 202613.6% +25.0 pp+30.7 pp
BLLNBillionToOne, Inc.LTM Jun 202610.9% +24.4 pp—
HSTMHealthStream, Inc.LTM Mar 20267.5% +0.7 pp+2.0 pp
CERTCertara, Inc.LTM Mar 20264.1% +2.3 pp-4.7 pp
TEMTempus AI, Inc.LTM Sep 2026-18.5% +3.4 pp+62.9 pp
HCATHealth Catalyst, Inc.LTM Mar 2026-19.2% +2.4 pp+39.1 pp
SOPHSOPHiA GENETICS S.A.LTM Mar 2026-88.4% +6.7 pp+92.9 pp
PSNLPersonalis, Inc.LTM Mar 2026-158.9% -80.6 pp—
Peer median (excluding SOPH) 7.5%+2.4 pp+11.3 pp

Competitors are the stored peer set for SOPH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue40.45M47.56M62.37M65.17M77.27M
Cost of Revenue15.23M16.31M19.46M21.24M29.46M
Gross Profit25.22M31.25M42.91M43.94M47.81M
Gross Margin62.4%65.7%68.8%67.4%61.9%
Research & Development26.58M35.37M36.97M34.37M33.57M
Selling, General & Admin70.24M84.08M81.72M76.32M85.17M
Operating Expenses96.71M119.08M117.74M110.51M118.74M
Depreciation & Amortization3.61M5.57M8.34M8.6M9.53M
EBITDA(69.24M)(81.38M)(69.57M)(50.76M)(64.4M)
EBITDA Margin-171.2%-171.1%-111.5%-77.9%-83.3%
Operating Income(71.49M)(87.82M)(74.83M)(66.57M)(70.93M)
Operating Margin-176.7%-184.7%-120.0%-102.1%-91.8%
Interest Income20K1.32M4.55M3.36M1.87M
Interest Expense658K639K588K1.91M4.55M
Other Income / Expenses(2.02M)238K(3.67M)5.3M(7.56M)
Income Before Tax(73.51M)(87.59M)(78.5M)(61.27M)(78.49M)
Pre-Tax Margin-181.7%-184.2%-125.9%-94.0%-101.6%
Income Tax Expense168K(136K)486K1.22M512K
Net Income(73.68M)(87.45M)(78.98M)(62.49M)(79M)
Net Margin-182.1%-183.9%-126.6%-95.9%-102.2%
EPS (Basic)(1.33)(1.36)(1.22)(0.95)(1.17)
EPS (Diluted)(1.33)(1.36)(1.22)(0.95)(1.17)
Weighted Avg Shares55.3M64.1M64.75M65.78M67.54M
Weighted Avg Shares (Diluted)55.3M64.1M64.75M65.78M67.54M

SOPHiA GENETICS S.A.

NASDAQ:SOPH

Intrinsic Alpha fair value

Locked

Current Price

$7.47

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.